WEDNESDAY, Sept. 15 (HealthDay News) -- Neuroimaging of patients with idiopathic rapid-eye-movement sleep behavior disorder (IRBD) can identify those at risk for developing neurodegenerative diseases, such as Parkinson's disease or dementia, before any symptoms of those conditions appear, according to a study published online Sept. 15 in The Lancet Neurology.